A carregar...
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
BACKGROUND: Resistance to isoniazid is the most common form of drug-resistance in tuberculosis. However only a tiny proportion of TB patients in the world have access to isoniazid drug susceptibility testing—the widely implemented Xpert MTB/RIF technology only tests for resistance to rifampicin. Pat...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6279036/ https://ncbi.nlm.nih.gov/pubmed/30513085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206658 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|